Getinge, a worldwide medtech innovator, is set to amplify its impact on the Indian market through the utilization of its India Innovation Centre (IIC) and by cultivating synergistic relationships with industry and academia, addressing a global market. The company holds a substantial market share in India across various product segments, including ventilators (30%), heart-lung machines (50%), intra-aortic balloon pumps (70%), extracorporeal membrane oxygenation (ECMO) (90%), and operating room tables (25%).
Aruna Nayak, Managing Director of Getinge India Pvt. Ltd., underscored the company’s key role in India’s healthcare sector advancements, notably during the COVID-19 pandemic. Getinge provided essential support to healthcare workers by delivering record installations of advanced ventilators and ECMO products. Additionally, their service engineers tackled nearly 10,000 service calls related to these devices.
Nayak further noted that India is now among Getinge’s top 10 markets worldwide, and the company is actively collaborating with 10,000 Indian hospitals to develop a world-class infrastructure. Getinge is dedicated to introducing, manufacturing, and distributing state-of-the-art technologies and devices in India, ensuring their availability in the US and the European Union. As healthcare infrastructure investments continue to increase, the company is prepared to cater to the Indian market with its high-quality products.
Pursuing their strategy for India, Getinge established an Innovation Centre in Bangalore in January 2020, focusing on the development of cutting-edge and economically viable solutions for emergency critical care and clinical trials. Furthermore, Getinge has partnered with IIT Bombay’s School of Biomedical Engineering to develop inventive and cost-effective emergency critical care solutions, incorporating knowledge gained from the pandemic.
Author
